Acceptability and Consumer Willingness to pay for a hypothetical HIV vaccine in Northern Brazil: A cross-sectional study and the implications

References

• Adebimpe, W. O., Badru, N. D., Adeoye, O. A., & Osifo, J. (2020). Willingness of people living with human immunodeficiency virus/acquired immunodeficiency syndrome to pay for treatment and preventive services in human immunodeficiency virus care centers in Osogbo, Osun State. Medical Journal of Babylon, 17, 84–88. https://doi.org/https://doi.org/10.4103/MJBL.MJBL_29_19
   Google Scholar
• Agência Nacional de Vigilância Sanitária (Anvisa). (2021). Lista de preços de medicamentos. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/precos
   Google Scholar
• Ahmed, S., Hoque, M. E., Sarker, A. R., Sultana, M., Islam, Z., Gazi, R., & Khan, J. A. (2016). Willingness-to-pay for community-based health insurance among informal workers in Urban Bangladesh. PloS One, 11(2), e0148211. https://doi.org/https://doi.org/10.1371/journal.pone.0148211
   PubMed Web of Science ®Google Scholar
• Athie, T. S., Nascimento, G. C., Costa, J. M. L., Silva, J. S., Reis, E. A., Martin, A. P., Godman, B., & Godói, I. P. D. (2021). Willingness to pay for a hypothetical Chagas disease vaccine in Northern Brazil: A cross-sectional study and the implications. Journal of Comparative Effectiveness Research, 10(8), 659–614. https://doi.org/https://doi.org/10.2217/cer-2021-0241
   PubMed Web of Science ®Google Scholar
• Atlas de desenvolvimento humano no Brasil. (2013). Perfil. www.atlasbrasil.org.br/2013/pt/perfil
   Google Scholar
• Barouch, D. H., Alter, G., Broge, T., Linde, C., Ackerman, M. E., Brown, E. P., Borducchi, E. N., Smith, K. M., Nkolola, J. P., Liu, J., Shields, J., Parenteau, L., Whitney, J. B., Abbink, P., Ng'ang'a, D. M., Seaman, M. S., Lavine, C. L., Perry, J. R., Li, W., … Schuitemaker, H. (2015). Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys. Science (New York, N.Y.), 349(6245), 320–324. https://doi.org/https://doi.org/10.1126/science.aab3886
   PubMed Web of Science ®Google Scholar
• Barros, S. G., & Vieira, S. L. M. (2017). A terapia antirretroviral combinada, a política de controle da Aids e as transformações do Espaço Aids no Brasil dos anos 1990. Saúde em Debate, 41(spe3), 114–128. https://doi.org/https://doi.org/10.1590/0103-11042017s309
   Google Scholar
• Bishai, D., Pariyo, G., Ainsworth, M., & Hill, K. (2004). Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bulletin of the World Health Organization, 82(9), 652–660. https://apps.who.int/iris/bitstream/handle/10665/269236/PMC2622986.pdf?sequence=1&isAllowed=y
   PubMed Web of Science ®Google Scholar
• Brasil. Banco Central do Brasil. (2020b). Conversor de Moedas. https://www.bcb.gov.br/conversao
   Google Scholar
• Brasil. Ministério da Saúde. (2008). Portaria n_ 2.587, de 30 de Outubro de 2008. Brasília. http://conitec.gov.br/images/Legislacao/Portaria2587_30.10.2008.pdf
   Google Scholar
• Brasil. Ministério da Saúde. (2014). Caderno de Informação da Saúde Suplementar – Beneficiários, Operadoras e Planos. http://www.ans.gov.br/images/stories/Materiais_para_pesquisa/Perfil_setor/Caderno_informacao_saude_suplementar/2014_mes12_caderno_informacao.pdf
   Google Scholar
• Brasil. Ministério da Saúde. (2018). Boletim Epidemiológico HIV/Aids. Brasília. http://www.aids.gov.br/pt-br/pub/2018/boletim-epidemiologico-hivaids-2018
   Google Scholar
• Brasil. Ministério da Saúde. (2019a). Boletim Epidemiológico de HIV e Aids. Brasília. http://www.aids.gov.br/pt-br/pub/2019/boletim-epidemiologico-de-hivaids-2019
   Google Scholar
• Brasil. Ministério da Saúde. (2019b). Brasil mais do que dobra o tempo de sobrevida de pessoas com aids. Brasília. http://www.aids.gov.br/pt-br/noticias/brasil-mais-do-que-dobra-o-tempo-de-sobrevida-de-pessoas-com-aids
   Google Scholar
• Brasil. Ministério da Saúde. (2019c). Boletim Vacinas e Novas Tecnologias de Prevenção N.33. Brasília. http://giv.org.br/boletimvacinas/33/
   Google Scholar
• Brasil. Ministério da Saúde. (2020a). Resolução CMED n ° 2, de 05 de março de 2004. Brasília. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/air/arquivos/5517json-file-1/view
   Google Scholar
• Brasil. Ministério da Saúde. (2021a). SI-PNI - Sistema de Informação do Programa Nacional de Imunizações. Brasília. http://pni.datasus.gov.br/apresentacao.asp
   Google Scholar
• Brasil. Ministério da Saúde. (2021b). Plano Nacional de operacionalização da vacina contra a COVID-19. Brasília. https://www.gov.br/saude/pt-br/media/pdf/2021/marco/23/plano-nacional-de-vacinacao-covid-19-de-2021
   Google Scholar
• Brasil. Ministério da Saúde. (2021c). Brasil Imunizado, saúde realiza maior distribuição de vacinas covid-19 de uma vez. Brasília. https://www.gov.br/saude/pt-br/assuntos/noticias/saude-realiza-maior-distribuicao-de-vacinas-covid-19-de-uma-unica-vez
   Google Scholar
• Brasil. Ministério da Saúde. (1990). Lei N° 8.080 de 19 de setembro de 1990. Brasília. http://www.planalto.gov.br/ccivil_03/leis/l8080.htm
   Google Scholar
• Brasil. Portal da transparência. (2020c). Atendimento a população com medicamentos para tratamento dos portadores de hiv/aids e outras doenças sexualmente transmissíveis. Brasília. http://www.portaltransparencia.gov.br/programas-e-acoes/acao/4370-atendimento-a-populacao-com-medicamentos-para-tratamento-dos-portadores-de-hiv-aids-eoutras-doencas-sexualmente-transmissiveis?ano=2020.
   Google Scholar
• Cameron, M. P., Newman, P. A., Roungprakhon, S., & Scarpa, R. (2013). The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine, 31(36), 3712–3717. https://doi.org/https://doi.org/10.1016/j.vaccine.2013.05.089
   PubMed Web of Science ®Google Scholar
• Carvalho, D. R., Silva, C. A. T., Oliveira, R. M. A., Gomes, A. M., & Oliveira, R. M. A. (2011). Custos no tratamento ambulatorial daHIV/AIDS: um estudo de caso no Hospital-Dias de Natal/RN. XVIII Congresso Brasileiro de Custos, 1, 1–16. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiIiKaz19jwAhVkJrkGHZ-1BfIQFjABegQIAxAD&url=https%3A%2F%2Fanaiscbc.emnuvens.com.br%2Fanais%2Farticle%2Fdownload%2F496%2F496&usg=AOvVaw2aedaElSONln10duXYLTQ3
   Google Scholar
• Chen, C. W., Saubi, N., & Joseph-Munné, J. (2020). Design concepts of virus-like particle-based HIV-1 vaccines. Frontiers in Immunology, 11, 573157. https://doi.org/https://doi.org/10.3389/fimmu.2020.573157
   PubMed Web of Science ®Google Scholar
• Costa, J. M. L., Nascimento, G. C., Athie, T. S., Silva, J. S., Reis, E. A., Martin, A. P., Godman, B., & Godói, I. P. D. (2022). Willingness to pay for a hypothetical Malaria vaccine in Brazil: A cross-sectional study and the implications. Journal of Comparative Effectiveness Research. https://doi.org/https://doi.org/10.2217/cer-2021-0073
   Google Scholar
• Cruz SOD. (2019). Construção, caracterização biológica e imunológica de vírus recombinante de vírus vacinal da febre amarela 17d, que expressam o fator de infetividade viral (vif) do vírus da imunodeficiência símia sivmac239. Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil. https://www.arca.fiocruz.br/handle/icict/37773
   Google Scholar
• Esparza, J. (2013). A brief history of the global effort to develop a preventive HIV vaccine. Vaccine, 31(35), 3502–3518. https://doi.org/https://doi.org/10.1016/j.vaccine.2013.05.018
   PubMed Web of Science ®Google Scholar
• Fernandes, R., Ribeiro, P. A. C. P., Decimoni, T., Ferrarezzo, F., Zillmer, V., & Aquino, J. (2020). Tratamento do HIV/AIDS no Brasil: impacto da adesão sobre a utilização de recursos e custos. Jornal Brasileiro de Economia da Saúde, 12(1), 81–87. https://doi.org/https://doi.org/10.21115/JBES.v12.n1.p81-7
   Google Scholar
• Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O’Reilly, K. R., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS, 30(12), 1973–1983. https://doi.org/https://doi.org/10.1097/QAD.0000000000001145
   PubMed Web of Science ®Google Scholar
• Foss, A. M., Watts, C. H., Vickerman, P., & Heise, L. (2004). Condoms and prevention of HIV. BMJ (Clinical Research ed.), 329(7459), 185–186. https://doi.org/https://doi.org/10.1136/bmj.329.7459.185
   PubMed Web of Science ®Google Scholar
• G1. (2018). Pará é o quarto estado com mais casos de Aids no país, segundo ministério. Belém, Brasil. https://g1.globo.com/pa/para/noticia/2018/12/02/para-e-o-quarto-estado-com-mais-casos-de-aids-no-pais-segundo-ministerio.ghtml
   Google Scholar
• German Advisory Committee Blood, Subgroup ‘Assessment of Pathogens Transmissible by Blood. (2016). Human Immunodeficiency Virus (HIV). Transfusion Medicine and Hemotherapy, 43, 203–222. https://doi.org/https://doi.org/10.1159/000445852
   PubMed Web of Science ®Google Scholar
• Godói, I. P. D., Sarmento, T. T. R., Reis, E. A., Gargano, L. P., Brandão, C. M., Godman, B., Acurcio, F. A., Alvares-Teodoro, J., Guerra Júnior, A. A., & Ruas, C. M. (2021). Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: A cross-sectional study and the implications. Expert Review of Pharmacoeconomics & Outcomes Research, 3, 1–11. https://doi.org/https://doi.org/10.1080/14737167.2021.1931128
   Google Scholar
• Godói, I. P., Santos, A. S., Reis, E. A., Lemos, L. L., Brandão, C. M., Alvares, J., Acurcio, F. A., Godman, B., & Guerra Júnior, A. A. (2017). Consumer willingness to pay for dengue vaccine (CYD-TDV, Dengvaxia®) in Brazil; implications for future pricing considerations. Frontiers in Pharmacology, 8, 41. https://doi.org/https://doi.org/10.3389/fphar.2017.00041
   PubMed Web of Science ®Google Scholar
• Grupo Incentivo a Vida (GIV). (2019). Boletim de Vacinas e Novas Tecnologias de Prevenção. 46p. São Paulo. http://www.giv.org.br/boletimvacinas/pdf/boletim-vacinas-e-tecnologias-anti-hiv-33-giv.pdf
   Google Scholar
• Gustafsson-Wright, E., Asfaw, A., & Van der Gaag, J. (2009). Willingness to pay for health insurance: An analysis of the potential market for new low-cost health insurance products in Namibia. Social Science & Medicine (1982), 69(9), 1351–1359. https://doi.org/https://doi.org/10.1016/j.socscimed.2009.08.011
   PubMed Web of Science ®Google Scholar
• Haab, T. C., & McConnell, K. E. (2003). Valuing environmental and natural resources: the econometrics of non-market valuation. Edward Elgar Pub.
   Google Scholar
• Highleyman, L. (2019). Promising HIV vaccine to be tested with gay men and trans people. https://www.aidsmap.com/news/jul-2019/promising-hiv-vaccine-be-tested-gay-men-and-trans-people.
   Google Scholar
• Instituto Brasileiro de Geografia e Estatística (IBGE). (2020b). Pnad Educação 2019: Mais da Metade das Pessoas de 25 anos ou mais não completaram o Ensino médio. https://agenciadenoticias.ibge.gov.br/agencia-sala-de-imprensa/2013-agencia-de-noticias/releases/28285-pnad-educacao-2019-mais-da-metade-das-pessoas-de-25-anos-ou-mais-nao-completaram-o-ensino-medio
   Google Scholar
• Instituto Brasileiro de Geografia e Estatística. (IBGE). (2020a). Divulga o rendimento domiciliar per capita: 2019. https://agenciadenoticias.ibge.gov.br/agencia-sala-de-imprensa/2013-agencia-de-noticias/releases/26956-ibge-divulga-o-rendimento-domiciliar-per-capita-2019
   Google Scholar
• Instituto Brasileiro de Geografia e Estatística. (IBGE). (2021). Cidades e Estados. https://www.ibge.gov.br/cidades-e-estado/pa/belem.html
   Google Scholar
• Javan-Noughabi, J., Kavosi, Z., Faramarzi, A., & Khammarnia, M. (2017). Identification determinant factors on willingness to pay for health services in Iran. Health Economics Review, 7(1), 1–6. https://doi.org/https://doi.org/10.1186/s13561-017-0179-x
   PubMedGoogle Scholar
• Keyserlingk, C., & von Rhodes, B. (2007). Using contingent valuation in hypothetical settings: estimating the WTP for an HIV/AIDS vaccine. Journal of Interdisciplinary Economics, 18(1), 71–89. https://doi.org/https://doi.org/10.1177/02601079X07001800104
   Google Scholar
• Koup, R. A., Roederer, M., Lamoreaux, L., Fischer, J., Novik, L., Nason, M. C., Larkin, B. D., Enama, M. E., Ledgerwood, J. E., Bailer, R. T., Mascola, J. R., Nabel, G. J., Graham, B. S., … & VRC 010 Study Team. (2010). Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. PloS One, 5(2), e9015. https://doi.org/https://doi.org/10.1371/journal.pone.0009015
   PubMed Web of Science ®Google Scholar
• Lally, M., Gaitanis, M., Vallabhaneni, S., Reinert, S., Mayer, K., Zimet, G., & Rich, J. (2006). Willingness to receive an HIV vaccine among incarcerated persons. Preventive Medicine, 43(5), 402–405. https://doi.org/https://doi.org/10.1016/j.ypmed.2006.06.012
   PubMed Web of Science ®Google Scholar
• Lee, J.-S., Mogasale, V., Lim, J. K., Carabali, M., Sirivichayakul, C., Anh, D. D., Lee, K.-S., Thiem, V. D., Limkittikul, K., Tho, L. H., Velez, I. D., Osorio, J. E., Chanthavanich, P., da Silva, L. J., & Maskery, B. A. (2015). A multi-country study of the household willingness-to-pay for dengue vaccines: Household surveys in Vietnam, Thailand, and Colombia. PLoS Neglected Tropical Diseases, 9(6), e0003810. https://doi.org/https://doi.org/10.1371/journal.pntd.0003810
   PubMed Web of Science ®Google Scholar
• Lee, S. J., Brooks, R. A., Newman, P. A., Seiden, D., Sangthong, R., & Duan, N. (2008). HIV vaccine acceptability among immigrant Thai residents in Los Angeles: A mixed-method approach. AIDS Care, 20(10), 1161–1168. https://doi.org/https://doi.org/10.1080/09540120701855375
   PubMed Web of Science ®Google Scholar
• Long, L. C., Rosen, S. B., Brennan, A., Moyo, F., Sauls, C., Evans, D., Modi, S. L., Sanne, I., & Fox, M. P. (2016). Treatment outcomes and costs of providing antiretroviral therapy at a primary health clinic versus a hospital-based HIV clinic in South Africa. PloS One, 11(12), e0168118. https://doi.org/https://doi.org/10.1371/journal.pone.0168118
   PubMed Web of Science ®Google Scholar
• Luz, P. M., Osher, B., Grinsztejn, B., Maclean, R. L., Losina, E., Stern, M. E., Struchiner, C. J., Parker, R. A., Freedberg, K. A., Mesquita, F., Walensky, R. P., Veloso, V. G., & Paltiel, A. D. (2018). The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil. Journal of the International AIDS Society, 21(3), e25096. https://doi.org/https://doi.org/10.1002/jia2.25096
   PubMed Web of Science ®Google Scholar
• Mbachu, C., Okoli, C., Onwujekwe, O., & Enabulele, F. (2018). Willingness to pay for antiretroviral drugs among HIV and AIDS clients in south-east Nigeria. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy, 21(1), 270–278. https://doi.org/https://doi.org/10.1111/hex.12612
   PubMed Web of Science ®Google Scholar
• Melo, B., Rodrigues, L., Monteiro, J., Arruda, M., & Bomfim, M. (2018). Epidemiologia e aspectos imunopatológicos do vírus da imunodeficiência humana (HIV): revisão de literatura. Revista Ceuma Perspectivas, 31(1), 86–100. https://doi.org/https://doi.org/10.24863/rccp.v31i1.184
   Google Scholar
• Montessori, V., Press, N., Harris, M., Akagi, L., & Montaner, J. S (2004). Adverse effects of antiretroviral therapy for HIV infection. CMAJ: Canadian Medical Association Journal = Journal de l'Association medicale canadienne, 170 (2), 229–238.
   PubMed Web of Science ®Google Scholar
• Muniz Júnior, R. L., Godói, I. P., Reis, E. A., Garcia, M. M., Guerra-Júnior, A. A., Godman, B., & Ruas, C. M. (2019). Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. Expert Review of Pharmacoeconomics & Outcomes Research, 19(4), 473–482. https://doi.org/https://doi.org/10.1080/14737167.2019.1552136
   PubMed Web of Science ®Google Scholar
• Ngambi, P. G., Kalungia, A. C., Law, M. R., Kalemeera, F., Truter, I., Godman, B., & Munkombwe, D. (2017). Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa. Expert Review of Pharmacoeconomics & Outcomes Research, 17(5), 459–467. https://doi.org/https://doi.org/10.1080/14737167.2017.1364161
   PubMed Web of Science ®Google Scholar
• Nunn, A., Brinkley-Rubinstein, L., Rose, J., Mayer, K., Stopka, T., Towey, C., Harvey, J., Santamaria, K., Sabatino, K., Trooskin, S., & Chan, P. A. (2017). Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection. Journal of the International AIDS Society, 20(1), 21290. https://doi.org/https://doi.org/10.7448/IAS.20.1.21290
   PubMedGoogle Scholar
• Organização Pan-Americana da Saúde (OPAS). (2017). Folha informativa - HIV/aids. https://edisciplinas.usp.br/pluginfile.php/5624379/mod_resource/content/1/OPAS_OMS%20Brasil%20-%20Folha%20informativa%20-%20HIV_aids.html
   Google Scholar
• Palanca-Tan, R. (2008). The demand for a dengue vaccine: a contingent valuation survey in Metro Manila. Vaccine, 26(7), 914–923. https://doi.org/https://doi.org/10.1016/j.vaccine.2007.12.011
   PubMed Web of Science ®Google Scholar
• Paredes, R., & Clotet, B. (2010). Clinical management of HIV-1 resistance. Antiviral Res, 85(1), 245–265. https://doi.org/https://doi.org/10.1016/j.antiviral.2009.09.015
   PubMed Web of Science ®Google Scholar
• Quiros-Roldan, E., Magoni, M., Raffetti, E., Donato, F., Scarcella, C., Paraninfo, G., & Castelli, F. (2016). The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population. BMC Public Health, 16(1), 10. https://doi.org/https://doi.org/10.1186/s12889-016-3804-4
   PubMedGoogle Scholar
• Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J. G., Francis, D. P., Stablein, D., Birx, D. L., Chunsuttiwat, S., Khamboonruang, C., … Kim, J. H. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. The New England Journal of Medicine, 361(23), 2209–2220. https://doi.org/https://doi.org/10.1056/NEJMoa0908492
   PubMed Web of Science ®Google Scholar
• Robinson, H. L. (2018). HIV/AIDS Vaccines: 2018. Clinical Pharmacology and Therapeutics, 104(6), 1062–1073. https://doi.org/https://doi.org/10.1002/cpt.1208
   PubMed Web of Science ®Google Scholar
• Roser, M., & Ritchi, H. (2019). HIV/AIDS. https://ourworldindata.org/hiv-aids
   Google Scholar
• Santos, A. C. F., Mendes, B. S., Andrade, C. F., Carvalho, M. M. d., Espírito-Santo, L. R., D'Angelis, C. E. M., & Prince, K. A. d. (2020). Perfil epidemiológico dos pacientes internados por HIV no Brasil. Revista Eletrônica Acervo Saúde, 48(48), e3243–43. https://doi.org/https://doi.org/10.25248/reas.e3243.2020
   Google Scholar
• Sarmento, T., Godói, I. P., Reis, E. A., Godman, B., & Ruas, C. M. (2019). Consumer willingness to pay for a hypothetical chikungunya vaccine in Brazil and the implications. Expert Review of Pharmacoeconomics & Outcomes Research, 4, 1–8. https://doi.org/https://doi.org/10.1080/14737167.2020.1703181
   Google Scholar
• Sharp, P. M., & Hahn, B. H. (2011). Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspectives in Medicine, 1(1), a006841. https://doi.org/https://doi.org/10.1101/cshperspect.a006841
   PubMed Web of Science ®Google Scholar
• Shaw, G. M., & Hunter, E. (2012). HIV transmission. Cold Spring Harbor Perspectives in Medicine, 2(11), a006965. https://doi.org/https://doi.org/10.1101/cshperspect.a006965
   PubMed Web of Science ®Google Scholar
• Silva, M. F. B. (2018). Manifestações clínicas e oro faciais de pacientes vivendo com HIV na era pós-HAART. Universidade de São Paulo. Biblioteca Digital USP: Teses e Dissertações. https://teses.usp.br/teses/disponiveis/23/23154/tde-25062018-122402/pt-br.php
   Google Scholar
• Supervie, V., Viard, J. P., Costagliola, D., & Breban, R. (2014). Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: Systematic review and bayesian modeling. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 59(1), 115–122. https://doi.org/https://doi.org/10.1093/cid/ciu223
   PubMed Web of Science ®Google Scholar
• Suraratdecha, C., Stuart, R. M., Edwards, M., Moore, R., Liu, N., Wilson, D. P., & Albalak, R. (2020). Costs of providing HIV care and optimal allocation of HIV resources in Guyana. PloS One, 15(10), e0238499. https://doi.org/https://doi.org/10.1371/journal.pone.0238499
   PubMed Web of Science ®Google Scholar
• Tenório, H. A. A., Correia, D. S., Santos, A. G. S., Marques, E. S., Silva, E. S., & Subrinho, D. O. (2019). A visão do graduando de enfermagem quanto sua atuação no mercado de trabalho do Sistema Único de Saúde. Revista Eletrônica Acervo Saúde, 11(13), e841–209. https://doi.org/https://doi.org/10.25248/reas.e841.2019
   Google Scholar
• The Antiretroviral Therapy Cohort Collaboration. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The Lancet. HIV, 4(8), e349–e356. https://doi.org/https://doi.org/10.1016/S2352-3018(17)30066-8
   PubMed Web of Science ®Google Scholar
• United Nations Programme on HIV and AIDS (UNAIDS). (2020). Seizing the moment - Tackling entrenched inequalities to end epidemics. https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf
   Google Scholar
• United Nations Programme on HIV and AIDS (UNAIDS-Brasil). (2019). Estatísticas. https://unaids.org.br/estatisticas/
   Google Scholar
• Usman, S., & Usman, I. (2019). Vaccine development & AMP; participation in Sub Saharan Africa: How willing are young people in western Nigeria? : https://sti.bmj.com/content/95/Suppl_1/A166.2
   Google Scholar
• Vagiri, R., Meyer, J., Godman, B., Andries, G., & Gous, S. (2018). Relationship between adherence and health-related quality of life among HIV-patients in South Africa: Findings and implications. Academic Journals, 10, 121–132. https://doi.org/https://doi.org/10.5897/JAHR2018.0478
   Google Scholar
• Wang, B., Chen, G., Ratcliffe, J., Afzali, H., Giles, L., & Marshall, H. (2017). Adolescent values for immunization programs in Australia: A discrete choice experiment. PloS One, 12(7), e0181073. https://doi.org/https://doi.org/10.1371/journal.pone.0181073
   PubMed Web of Science ®Google Scholar
• Weisberg, S. (2005). Applied linear regression. 3rd ed. Wiley & Sons, Inc.
   Google Scholar
• Whittington, D., Matsui-Santana, O., Freiberger, J. J., Van Houtven, G., & Pattanayak, S. (2002). Private demand for a HIV/AIDS vaccine: Evidence from Guadalajara, Mexico. Vaccine, 20(19–20), 2585–2591. https://doi.org/https://doi.org/10.1016/S0264-410X(02)00152-4
   PubMed Web of Science ®Google Scholar
• Whittington, D., Suraratdecha, C., Poulos, C., Ainsworth, M., Prabhu, V., & Tangcharoensathien, V. (2008). Household demand for preventive HIV/AIDS vaccines in Thailand: do husbands' and wives' preferences differ? Value in Health: The journal of the International Society for Pharmacoeconomics and Outcomes Research, 11(5), 965–974. https://doi.org/https://doi.org/10.1111/j.1524-4733.2007.00312.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020). HIV/AIDS - key facts. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hiv-aids
   Google Scholar
• World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2nd ed. World Health Organization. 429p. :https://apps.who.int/iris/handle/10665/208825
   Google Scholar
• Young, A. M., DiClemente, R. J., Halgin, D. S., Sterk, C. E., & Havens, J. R. (2014). HIV vaccine acceptability among high-risk drug users in Appalachia: A cross-sectional study. BMC Public Health, 14, 537. https://doi.org/https://doi.org/10.1186/1471-2458-14-537
   PubMed Web of Science ®Google Scholar